{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T22:48:21Z","timestamp":1789944501999,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T00:00:00Z","timestamp":1111622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T00:00:00Z","timestamp":1111622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Background<\/jats:title>\n                        <jats:p>In primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) fatigue is a major clinical problem. Abnormal amino acid (AA) patterns have been implicated in the development of fatigue in several non-hepatological conditions but for PBC and PSC no data are available. This study aimed to identify abnormalities in AA patterns and to define their relation with fatigue.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Plasma concentrations of tyrosine, tryptophan, phenylalanine, valine, leucine and isoleucine were determined in plasma of patients with PBC (n = 45), PSC (n = 27), chronic hepatitis C (n = 22) and healthy controls (n = 73). Fatigue and quality of life were quantified using the Fisk fatigue severity scale, a visual analogue scale and the SF-36.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Valine, isoleucine, leucine were significantly decreased in PBC and PSC. Tyrosine and phenylalanine were increased (p &lt; 0.0002) and tryptophan decreased (p &lt; 0.0001) in PBC. In PBC, but not in PSC, a significant inverse relation between tyrosine concentrations and fatigue and quality of life was found. Patients without fatigue and with good quality of life had increased tyrosine concentrations compared to fatigued patients. Multivariate analysis indicated that this relation was independent from disease activity or severity or presence of cirrhosis.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>In patients with PBC and PSC, marked abnormalities in plasma AA patterns occur. Normal tyrosine concentrations, compared to increased concentrations, may be associated with fatigue and diminished quality of life.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/1471-230x-5-11","type":"journal-article","created":{"date-parts":[[2005,3,26]],"date-time":"2005-03-26T07:16:10Z","timestamp":1111821370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The relation between plasma tyrosine concentration and fatigue in primary biliary cirrhosis and primary sclerosing cholangitis"],"prefix":"10.1186","volume":"5","author":[{"given":"Pieter CJ","family":"ter Borg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durk","family":"Fekkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Maarten","family":"Vrolijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk R","family":"van Buuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,3,24]]},"reference":[{"key":"116_CR1","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/hep.510300101","volume":"30","author":"P Angulo","year":"1999","unstructured":"Angulo P, Lindor KD: Primary sclerosing cholangitis. Hepatology. 1999, 30: 325-332. 10.1002\/hep.510300101.","journal-title":"Hepatology"},{"key":"116_CR2","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0140-6736(97)05419-6","volume":"350","author":"J Neuberger","year":"1997","unstructured":"Neuberger J: Primary biliary cirrhosis. Lancet. 1997, 350: 875-879. 10.1016\/S0140-6736(97)05419-6.","journal-title":"Lancet"},{"key":"116_CR3","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/j.1572-0241.2000.01857.x","volume":"95","author":"PM Huet","year":"2000","unstructured":"Huet PM, Deslauriers J, Tran A, Faucher C, Charbonneau J: Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. Am J Gastroenterol. 2000, 95: 760-767. 10.1016\/S0002-9270(99)00916-8.","journal-title":"Am J Gastroenterol"},{"key":"116_CR4","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/gut.43.5.705","volume":"43","author":"K Cauch-Dudek","year":"1998","unstructured":"Cauch-Dudek K, Abbey S, Stewart DE, Heathcote EJ: Fatigue in primary biliary cirrhosis. Gut. 1998, 43: 705-710.","journal-title":"Gut"},{"key":"116_CR5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S0016-5085(85)80141-4","volume":"88","author":"RH Wiesner","year":"1985","unstructured":"Wiesner RH, LaRusso NF, Ludwig J, Dickson ER: Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology. 1985, 88: 108-114.","journal-title":"Gastroenterology"},{"key":"116_CR6","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0168-8278(00)80385-2","volume":"32","author":"MI Prince","year":"2000","unstructured":"Prince MI, James OF, Holland NP, Jones DE: Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use. J Hepatol. 2000, 32: 368-373. 10.1016\/S0168-8278(00)80385-2.","journal-title":"J Hepatol"},{"key":"116_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0361-9230(03)00021-2","volume":"60","author":"J McGuire","year":"2003","unstructured":"McGuire J, Ross GL, Price H, Mortensen N, Evans J, Castell LM: Biochemical markers for post-operative fatigue after major surgery. Brain Res Bull. 2003, 60: 125-130. 10.1016\/S0361-9230(03)00021-2.","journal-title":"Brain Res Bull"},{"key":"116_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1042\/CS20020354","volume":"105","author":"E Georgiades","year":"2003","unstructured":"Georgiades E, Behan WM, Kilduff LP, Hadjicharalambous M, Mackie EE, Wilson J, Ward SA, Pitsiladis YP: Chronic fatigue syndrome: new evidence for a central fatigue disorder. Clin Sci (Lond). 2003, 105: 213-218.","journal-title":"Clin Sci (Lond)"},{"key":"116_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF02069503","volume":"11","author":"RF Butterworth","year":"1996","unstructured":"Butterworth RF: Neuroactive amino acids in hepatic encephalopathy. Metab Brain Dis. 1996, 11: 165-173.","journal-title":"Metab Brain Dis"},{"key":"116_CR10","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1093\/clinids\/18.Supplement_1.S79","volume":"18 Suppl 1","author":"JD Fisk","year":"1994","unstructured":"Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF: Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis. 1994, 18 Suppl 1: S79-83.","journal-title":"Clin Infect Dis"},{"key":"116_CR11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JEJ Ware","year":"1992","unstructured":"Ware JEJ, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992, 30: 473-483.","journal-title":"Med Care"},{"key":"116_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0378-4347(95)00111-U","volume":"669","author":"D Fekkes","year":"1995","unstructured":"Fekkes D, van Dalen A, Edelman M, Voskuilen A: Validation of the determination of amino acids in plasma by high-performance liquid chromatography using automated pre-column derivatization with o-phthaldialdehyde. J Chromatogr B Biomed Appl. 1995, 669: 177-186. 10.1016\/0378-4347(95)00111-U.","journal-title":"J Chromatogr B Biomed Appl"},{"key":"116_CR13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/gut.23.5.362","volume":"23","author":"MY Morgan","year":"1982","unstructured":"Morgan MY, Marshall AW, Milsom JP, Sherlock S: Plasma amino-acid patterns in liver disease. Gut. 1982, 23: 362-370.","journal-title":"Gut"},{"key":"116_CR14","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1136\/gut.19.11.1068","volume":"19","author":"MY Morgan","year":"1978","unstructured":"Morgan MY, Milsom JP, Sherlock S: Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease. Gut. 1978, 19: 1068-1073.","journal-title":"Gut"},{"key":"116_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/00000658-197803000-00024","volume":"187","author":"AR Smith","year":"1978","unstructured":"Smith AR, Rossi-Fanelli F, Ziparo V, James JH, Perelle BA, Fischer JE: Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma. Ann Surg. 1978, 187: 343-350.","journal-title":"Ann Surg"},{"key":"116_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-1-4615-0135-0_3","volume":"527","author":"AL Mellor","year":"2003","unstructured":"Mellor AL, Munn D, Chandler P, Keskin D, Johnson T, Marshall B, Jhaver K, Baban B: Tryptophan catabolism and T cell responses. Adv Exp Med Biol. 2003, 527: 27-35.","journal-title":"Adv Exp Med Biol"},{"key":"116_CR17","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1001\/jama.285.17.2196","volume":"285","author":"J Goldblatt","year":"2001","unstructured":"Goldblatt J, James OF, Jones DE: Grip strength and subjective fatigue in patients with primary biliary cirrhosis. Jama. 2001, 285: 2196-2197. 10.1001\/jama.285.17.2196.","journal-title":"Jama"},{"key":"116_CR18","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1046\/j.1440-1746.1999.01968.x","volume":"14","author":"JP Watson","year":"1999","unstructured":"Watson JP, Jones DE, James OF, Cann PA, Bramble MG: Case report: oral antioxidant therapy for the treatment of primary biliary cirrhosis: a pilot study. J Gastroenterol Hepatol. 1999, 14: 1034-1040. 10.1046\/j.1440-1746.1999.01968.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"116_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1046\/j.1365-2036.2003.01398.x","volume":"17","author":"MI Prince","year":"2003","unstructured":"Prince MI, Mitchison HC, Ashley D, Burke DA, Edwards N, Bramble MG, James OF, Jones DE: Oral antioxidant supplementation for fatigue associated with primary biliary cirrhosis: results of a multicentre, randomized, placebo-controlled, cross-over trial. Aliment Pharmacol Ther. 2003, 17: 137-143. 10.1046\/j.1365-2036.2003.01398.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"116_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0893-133X(01)00231-7","volume":"25","author":"NP Verhoeff","year":"2001","unstructured":"Verhoeff NP, Kapur S, Hussey D, Lee M, Christensen B, Psych C, Papatheodorou G, Zipursky RB: A simple method to measure baseline occupancy of neostriatal dopamine D2 receptors by dopamine in vivo in healthy subjects. Neuropsychopharmacology. 2001, 25: 213-223. 10.1016\/S0893-133X(01)00231-7.","journal-title":"Neuropsychopharmacology"},{"key":"116_CR21","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0091-3057(02)01028-6","volume":"74","author":"NP Verhoeff","year":"2003","unstructured":"Verhoeff NP, Christensen BK, Hussey D, Lee M, Papatheodorou G, Kopala L, Rui Q, Zipursky RB, Kapur S: Effects of catecholamine depletion on D(2) receptor binding, mood, and attentiveness in humans: a replication study. Pharmacol Biochem Behav. 2003, 74: 425-432. 10.1016\/S0091-3057(02)01028-6.","journal-title":"Pharmacol Biochem Behav"},{"key":"116_CR22","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1097\/00005768-200112000-00020","volume":"33","author":"Y Avraham","year":"2001","unstructured":"Avraham Y, Hao S, Mendelson S, Berry EM: Tyrosine improves appetite, cognition, and exercise tolerance in activity anorexia. Med Sci Sports Exerc. 2001, 33: 2104-2110. 10.1097\/00005768-200112000-00020.","journal-title":"Med Sci Sports Exerc"},{"key":"116_CR23","first-page":"364","volume":"63","author":"JO Owasoyo","year":"1992","unstructured":"Owasoyo JO, Neri DF, Lamberth JG: Tyrosine and its potential use as a countermeasure to performance decrement in military sustained operations. Aviat Space Environ Med. 1992, 63: 364-369.","journal-title":"Aviat Space Environ Med"},{"key":"116_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0361-9230(98)00163-4","volume":"48","author":"JB Deijen","year":"1999","unstructured":"Deijen JB, Wientjes CJ, Vullinghs HF, Cloin PA, Langefeld JJ: Tyrosine improves cognitive performance and reduces blood pressure in cadets after one week of a combat training course. Brain Res Bull. 1999, 48: 203-209. 10.1016\/S0361-9230(98)00163-4.","journal-title":"Brain Res Bull"},{"key":"116_CR25","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/gut.2003.016766","volume":"53","author":"DM Forton","year":"2004","unstructured":"Forton DM, Patel N, Prince M, Oatridge A, Hamilton G, Goldblatt J, Allsop JM, Hajnal JV, Thomas HC, Bassendine M, Jones DE, Taylor-Robinson SD: Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels. Gut. 2004, 53: 587-592. 10.1136\/gut.2003.016766.","journal-title":"Gut"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-5-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1471-230X-5-11\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-5-11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-5-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T13:00:11Z","timestamp":1728306011000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-5-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,24]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,12]]}},"alternative-id":["116"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-5-11","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,24]]},"assertion":[{"value":"31 August 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"11"}}